Junk...Yes and no. Q3 will include the shipments for initial stocking of the stores. In my estimation, I can't see where this is going to be more than an incremental $200K or so, top line. The big question for the future is acceptance of the technology. If it is well-received then EVERY pharmacy and mega-store will have to have it. Then, it is not a big step for other applications. The result of this mini-foray into the mainstream is extremely huge for the future. So experiential data is key in determining our chance for success.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.